Arecor Therapeutics PLC

AREC

Company Profile

  • Business description

    Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, Germany, Italy, the Rest of Europe, the USA, and India, out of which the majority is from the UK.

  • Contact

    Chesterford Research Park
    Little Chesterford
    Saffron WaldenCB10 1XL
    GBR

    T: +44 1223426060

    E: [email protected]

    https://www.arecor.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    43

Stocks News & Analysis

stocks

Best and worst performing ASX sectors of 2024

Exploring the ASX sectors that moved the market this year.
stocks

2 ASX companies with the traits of a long-term winner

Two companies that show promising signs of handsomely rewarding shareholders.
video

Our outlook for 2025

Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,465.0044.500.53%
CAC 407,393.7613.020.18%
DAX 4020,024.66115.520.58%
Dow JONES (US)42,417.35126.87-0.30%
FTSE 1008,260.0987.071.07%
HKSE19,623.32436.63-2.18%
NASDAQ19,264.9745.83-0.24%
Nikkei 22539,894.54386.62-0.96%
NZX 50 Index13,110.74159.27-1.20%
S&P 5005,867.4514.18-0.24%
S&P/ASX 2008,201.2042.100.52%
SSE Composite Index3,262.5689.20-2.66%

Market Movers